Both in vitro and in vivo experiments demonstrated that Sema3E could inhibit the proliferation of gastric cancer cell lines, which was achieved by inhibition of entry into S phase during cell cycle progression and by promotion of apoptosis. Here, SEMA3E is linked to gastric cancer.